Cargando…
Sprouty2 enhances the tumorigenic potential of glioblastoma cells
BACKGROUND: Sprouty2 (SPRY2), a feedback regulator of receptor tyrosine kinase (RTK) signaling, has been shown to be associated with drug resistance and cell proliferation in glioblastoma (GBM), but the underlying mechanisms are still poorly defined. METHODS: SPRY2 expression and survival patterns o...
Autores principales: | Park, Jong-Whi, Wollmann, Guido, Urbiola, Carles, Fogli, Barbara, Florio, Tullio, Geley, Stephan, Klimaschewski, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280149/ https://www.ncbi.nlm.nih.gov/pubmed/29635363 http://dx.doi.org/10.1093/neuonc/noy028 |
Ejemplares similares
-
Subcellular Localization of Sprouty2 in Human Glioma Cells
por: Hausott, Barbara, et al.
Publicado: (2019) -
Metabolism-based isolation of invasive glioblastoma cells with specific gene signatures and tumorigenic potential
por: Smith, Stuart James, et al.
Publicado: (2020) -
A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR
por: Al-Mayhani, Talal F, et al.
Publicado: (2019) -
Sprouty2—a Novel Therapeutic Target in the Nervous System?
por: Hausott, Barbara, et al.
Publicado: (2018) -
CRN2 enhances the invasiveness of glioblastoma cells
por: Ziemann, Anja, et al.
Publicado: (2013)